Sickle Cell Disease Treatment Market Forecast: What to Expect by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Sickle Cell Disease Treatment Market By 2029?

The sickle cell disease treatment market size has witnessed rapid growth in recent years. Forecasts indicate an increase from $2.95 billion in 2024 to $3.51 billion in 2025, maintaining a compound annual growth rate (CAGR) of 18.7%. This historic growth can be ascribed to elements like disease understanding, blood transfusions, pain management, and hydroxyurea therapy.

The sickle cell disease treatment market size is projected to experience substantial growth in the coming years. It is anticipated to expand to $6.72 billion in 2029, achieving a compound annual growth rate (CAGR) of 17.7%. This expansion during the forecast period is fueled by factors such as gene editing and gene therapy, the introduction of new drugs, the widespread adoption of telemedicine and remote monitoring, and various global health initiatives. Prominent trends expected in this period include the emergence of curative therapies, innovative pain management alternatives, increased global collaborations, and enhanced patient advocacy and engagement.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13048&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Sickle Cell Disease Treatment Industry?

The rising need for blood transfusions is anticipated to stimulate expansion within the sickle cell disease treatment market moving ahead. This medical procedure involves transferring blood or its components from a donor to a recipient. For individuals with sickle cell disease (SCD), blood transfusions are vital for enhancing the blood’s oxygen-carrying capacity and mitigating complications stemming from vaso-occlusion. An illustration of this demand comes from January 2022, when Mid-Atlantic Long-Term Care, a US-based provider of specialized 24-hour triage on-call service, reported that approximately 29,000 units of red blood cells, 5,000 units of platelets, and 6,500 units of plasma are required daily in the US. Consequently, the heightened requirement for blood transfusions is fostering the expansion of the sickle cell disease treatment market.

What Are The Segment Types Shaping The Sickle Cell Disease Treatment Market?

The sickle cell disease treatmentmarket covered in this report is segmented –

1) By Treatment Modality: Blood Transfusion; Pharmacotherapy; Bone Marrow Transplant

2) By Disease Type: Sickle Cell Anemia; Hemoglobin Sickle C Disease (HbSC); Other Disease Types

3) By Route Of Administration: Oral; Parenteral

4) By End-User: Hospitals; Specialty Clinics; Other End-Users

Subsegments:

1) By Blood Transfusion: Regular Blood Transfusion; Exchange Transfusion

2) By Pharmacotherapy: Hydroxyurea; L-Glutamine; Voxelotor; Crizanlizumab

3) By Bone Marrow Transplant: Allogeneic Transplant; Autologous Transplant

What Trends Are Expected To Drive The Sickle Cell Disease Treatment Market?

Major companies in the sickle cell disease treatment market are prioritizing the development of new oral suspension drugs. This focus aims to enhance patient compliance, improve drug efficacy, and provide more convenient treatment options, particularly for pediatric and elderly patients. Oral suspension drugs are liquid medications that contain solid particles mixed within a liquid, specifically designed to simplify swallowing for patients, especially children or those who struggle with pills. For instance, in March 2024, Akums Drugs and Pharmaceuticals Ltd., an India-based pharmaceutical preparation manufacturing company, launched a room temperature-stable oral suspension of Hydroxyurea. This medication for SCD is an affordable, room-temperature-stable treatment developed to increase accessibility in India. Priced at less than 1% of imported options, it provides precise dosing with oral syringes, offering advantages to patients of all ages without requiring cold storage.

Which Leading Players Are Enhancing Their Sickle Cell Disease Treatment Market Presence Worldwide?

Major companies operating in the sickle cell disease treatment market are Sun Pharmaceutical Industries Ltd., Pfizer Inc., Johnson & Johnson Private Limited, Merck & Co Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Vertex Pharmaceuticals Incorporated, Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Silver Lake Research Corporation0.45, Global Blood Therapeutics Inc., Acceleron Pharma Inc., Sangamo Therapeutics Inc., Medunik USA Inc., Zydus Cadila Healthcare Ltd., Graphite Bio Inc., Addmedica, Emmaus Medical Inc., Bluebird bio Inc., CRISPR Therapeutics AG, GlycoMimetics Inc., Arena Pharmaceuticals Inc., Mast Therapeutics Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/sickle-cell-disease-treatment-global-market-report

Which Global Regions Are Influencing The Competitive Landscape Of The Sickle Cell Disease Treatment Market?

North America was the largest region in the sickle cell disease treatment market in 2024. The regions covered in sickle cell disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Sickle Cell Disease Treatment Market Report:

https://www.thebusinessresearchcompany.com/customise?id=13048&type=smp

Browse Through More Reports Similar to the Global Sickle Cell Disease Treatment Market 2025, By The Business Research Company

Blood Transfusion Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Patient Blood Management Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report

Anemia And Other Blood Disorder Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anemia-and-other-blood-disorder-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795